Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

348
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
348
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
Drug Nomenclature01:17

Drug Nomenclature

3.6K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
3.6K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

205
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
205
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

236
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
236
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

276
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
276

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MACRA: An Overview and Implications. Healthcare is taking the next step on the long road to value-based purchasing.

Healthcare executive·2018
Same author

Reinventing the Healthcare Workforce: Policies may alleviate short-term shortages, but emerging technologies will shape long-term solutions.

Healthcare executive·2018
Same author

The Path to a Lifetime Health Plan. Continuity of enrollment is valuable to consumers and health plans.

Healthcare executive·2018
Same author

Battling Opioid Addiction.

Healthcare executive·2018
Same author

Health Policy in the 2016 Election. Neither very liberal nor very conservative policies will gain traction under the new administration.

Healthcare executive·2016
Same author

Value-Based Purchasing Turns the Corner. The move away from fee for service holds some consequences for management strategy.

Healthcare executive·2016
Same journal

Developing Front-Line Physician Leaders.

Healthcare executive·2018
Same journal

Ensuring Healthcare Improvements Stick.

Healthcare executive·2018
Same journal

What's your Organization's Value Proposition?

Healthcare executive·2018
Same journal

Leading a Multigenerational Workforce.

Healthcare executive·2018
Same journal

The Election - A New Emphasis on State Innovation.

Healthcare executive·2018
Same journal

Supporting Patient Dignity, One Outfit at a Time.

Healthcare executive·2018
See all related articles

Related Experiment Video

Updated: Mar 22, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.4K

Drug Prices: A Policy Puzzle

Daniel B McLaughlin

    Healthcare Executive
    |April 29, 2016
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
    08:10

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

    Published on: April 9, 2012

    82.2K
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    10.3K

    Related Experiment Videos

    Last Updated: Mar 22, 2026

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
    19:57

    An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

    Published on: March 30, 2014

    19.4K
    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
    08:10

    Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test

    Published on: April 9, 2012

    82.2K
    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
    05:10

    Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

    Published on: December 11, 2016

    10.3K